PUBLICATION

Global Business Reports

AUTHORS

Catherine Howe, Neha Premjee

DOWNLOAD THE FULL PDF

India Pharmaceuticals 2017

Pharma & Life Sciences

India

November 28, 2017

India’s pharmaceutical industry, ranked third worldwide in terms of volume, is the largest supplier of generic drugs globally and a proponent of high-quality affordable medicines. The industry has posted double-digit growth over the last few years, rising to US$36.7 billion and projected to grow to US$40 billion by 2020. However, as price erosion continues to impact the market and competition increases, many of India’s pharmaceutical companies will be hard-pressed to continue pushing products into the market at ever-more affordable prices. A number of policies under discussion, outlined in the Draft Pharmaceutical Policy 2017, seek to address the challenges faced by Indian pharmaceutical companies. Implementation and open dialogue between government and industry will be key in ensuring its success.

RELATED INTERVIEWS MORE INTERVIEWS

Naresh Raisinghani

CEO & EXECUTIVE DIRECTOR, BMGI INDIA

BMGI India offers expertise is improving efficiencies in strategy, innovation, problem solving and business transformation.

Pharma & Life Sciences

India

Akshay Singh

MANAGING DIRECTOR, SGD PHARMA INDIA

Cogent Glass, recently acquired by SGD Pharma, is a manufacturer of Type I moulded and tubular glass vials for the pharmaceutical industry.

Pharma & Life Sciences

India

Harish Shah

MANAGING DIRECTOR, SIGNET

Signet is India’s largest excipient company with extensive activities extending to Bangladesh and the Middle East.

Pharma & Life Sciences

India

Shri. KT Rama Rao

GOVERNMENT OF TELANGANA

Telangana State contains one of India’s most important life science clusters and its Government explains to GBR its plans to maintain the State’s rapid industrial growth.

Pharma & Life Sciences

India

Raising the bar: India’s generic players compete for market share

India Pharmaceuticals 2017

As India’s domestic pharmaceutical market becomes increasingly crowded and the industry as a whole continues along the path of globalization, ...

Pharma & Life Sciences

India

Building Blocks: Bulk Drugs, Excipients and Intermediates

India Pharmaceuticals 2017

The largest supplier of generic drugs globally, India continues to fortify its reputation as a hub for the production of affordable quality medicines.